
Study Period | 2019 - 2030 |
Base Year For Estimation | 2024 |
Forecast Data Period | 2025 - 2030 |
CAGR | 5.90 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Diabetic Foot Ulcer Treatment Market Analysis
The Diabetic Foot Ulcer Treatment Market is expected to register a CAGR of 5.9% during the forecast period.
Diabetic Foot Ulcer Treatment Market Trends
Wound Dressings Segment is Anticipated to Hold a Significant Market Share in the Market
Based on product type, the wound dressings segment is expected to contribute a significant proportion of the market. A wide range of product availability, the introduction of advanced wound dressing products, and comparatively lower treatment costs are among the primary factors attributed to the growth of this segment. For instance, in June 2022, Collagen Matrix received pre-marketing authorization for fibrillar collagen wound dressing. This is an absorbent microfibrillar matrix that is used in the treatment of venous stasis ulcers, diabetic ulcers, and acute wounds, among others. In June 2022, Medline Industries, Inc. announced the launch of a new version of Optofoam Gentle EX foam dressing with an aim to treat pressure ulcers, leg ulcers, and others. Additionally, in January 2020, Convatec Group PLC introduced ConvaMax, intending to manage wounds including leg ulcers, pressure ulcers, diabetic foot ulcers, and others precisely. This results in the increasing adoption of wound care dressing products during the study period.
Furthermore, the recent advancement in wound dressings products, including hydrogel dressings and hydrocolloid dressing for the treatment of diabetic foot ulcers, bring a revolution to wound treatment. For instance, in February 2021, the University of Bath, in coordination with Lancaster University, launched a project to treat diabetic foot ulcers with the help of plasma-activated antimicrobial hydrogel therapy. This therapy involved dressing with an antimicrobial molecule and increasing the oxygen levels in the wound with an aim to promote healing and further restrict bacterial growth. This advancement in the wound dressing segment is poised to fuel the adoption rate of wound dressing products during the study period.
Therefore, the wound dressings segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America is Expected to Dominate the Diabetic Foot Ulcer Treatment Market
North America is expected to dominate the market owing to factors such as the rising prevalence of diabetes and increasing healthcare awareness among the general population on diabetic foot ulcers, among others. For instance, according to the International Diabetes Federation, there were an estimated 14 million adults in Mexico who had diabetes in 2021. Moreover, according to the Canadian Diabetes Association report published in 2022, the prevalence of diabetes was 14% among the Canadian population in 2022 and is expected to increase to 17% by the end of 2032. This increasing patient pool is increasing the healthcare burden for diabetic foot ulcer treatment in North America, resulting in the rising adoption of wound care products during the forecast period.
Additionally, increasing awareness of diabetic foot ulcers among the population in the United States, Canada, and Mexico is also rising the demand and adoption of available treatment options. For instance, Healogics, LLC promoted an awareness campaign on diabetes and related wounds in the United States in November 2022. During this campaign, wound care centers in the United States educated the common people on diabetes and diabetes-related chronic wounds, including diabetic foot ulcers.
Therefore, owing to the aforesaid factors, the growth of the studied market is anticipated in North America.

Diabetic Foot Ulcer Treatment Industry Overview
The Diabetic Foot Ulcer Treatment Market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The key players are Convatec Inc., 3M, and Integra LifeSciences, among others. The other players operating in the market are Coloplast Corp, Cardinal Health, Organogenesis Inc., Medline Industries, Inc., MIMEDX, and Smith+Nephew among others.
Diabetic Foot Ulcer Treatment Market Leaders
-
Convatec Inc.
-
3M
-
Integra LifeSciences
-
Coloplast Corp
-
Cardinal Health
- *Disclaimer: Major Players sorted in no particular order

Diabetic Foot Ulcer Treatment Market News
October 2022: Healthium Medtech, introduced the wound dressing portfolio 'Theruptor Novo' to treat chronic wounds, including diabetic foot ulcers. This strategy helped the company to widen its advanced wound care product offerings and cater to the rising demand for wound care products.
January 2022: Smith+Nephew received FDA clearance for PICO 7 and PICO 14 single-use negative pressure wound therapy to treat class I and class II wounds, including traumatic, subacute, burns, and diabetic foot ulcers. This strategy assisted the company to enhance its product reach to a large customer base.
Diabetic Foot Ulcer Treatment Industry Segmentation
As per the scope of the report, diabetic foot ulcer treatment is a hard-to-heal wound that is most prevalent in diabetic polyneuropathy patients around the globe.
The Diabetic Foot Ulcer Treatment Market is segmented by Product Type (Wound Dressing, Wound Care Devices, and Others), End-User (Hospitals and Clinics, Ambulatory Surgery Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (USD million) for the above segments.
By Product Type | Wound Dressings | ||
Wound Care Devices | |||
Other Product Types | |||
By End-User | Hospitals and Clinics | ||
Ambulatory Surgery Centers | |||
Other end-Users | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle-East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Diabetic Foot Ulcer Treatment Market Research FAQs
What is the current Diabetic Foot Ulcer Treatment Market size?
The Diabetic Foot Ulcer Treatment Market is projected to register a CAGR of 5.9% during the forecast period (2025-2030)
Who are the key players in Diabetic Foot Ulcer Treatment Market?
Convatec Inc., 3M, Integra LifeSciences, Coloplast Corp and Cardinal Health are the major companies operating in the Diabetic Foot Ulcer Treatment Market.
Which is the fastest growing region in Diabetic Foot Ulcer Treatment Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Diabetic Foot Ulcer Treatment Market?
In 2025, the North America accounts for the largest market share in Diabetic Foot Ulcer Treatment Market.
What years does this Diabetic Foot Ulcer Treatment Market cover?
The report covers the Diabetic Foot Ulcer Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Diabetic Foot Ulcer Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Diabetic Foot Ulcer Treatment Industry Report
Statistics for the 2025 Diabetic Foot Ulcer Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Diabetic Foot Ulcer Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.